Investing in the companies transforming brain health.

AI voice platform that screens and monitors mental health conditions through natural conversation — handles outpatient calls better than humans.

Best-in-class online psychiatric care covered by leading insurers, combining precision matching with evidence-based therapy.

Leading developer of psychedelics-based mental health therapies with a clinical-stage pipeline targeting major depressive disorder and anxiety.

Neuro-stimulation therapy platform that is 3x more effective than the status quo for treatment-resistant depression.

The leader in microbiome-based therapies for mental health, with a pipeline targeting depression, anxiety, and chronic pain via the gut-brain axis.

Leading provider of mental health resource portals for HR departments, helping employers deliver evidence-based support at scale.

Founded by Apple's former AI team, decoding brain behavior for precision brain health therapies using advanced ML.

Hybrid therapeutics platform combining transcranial ultrasound with AI-driven targeting for anxiety, depression, and neurodegenerative conditions.

Specialty mental health platform focused on women's health, providing targeted support for OB-GYN patients through integrated care pathways.

Mental health marketplace connecting patients with providers, streamlining access and care navigation at scale.

Digital health platform bridging metabolic science and psychiatry, enabling primary care physicians to address diet-driven mental health conditions.

AI infrastructure platform developing novel cognitive architectures for next-generation artificial intelligence systems.

Behavioral health platform delivering accessible, evidence-based care for patients across the behavioral health spectrum.

Developing next-generation psychedelic therapies targeting depression and anxiety through novel compound design.